Answers are grounded in this paper and cite their sources.
Microbial biotechnology plays a key role in developing alternative sources of raw materials and energy and in valorizing industrial by-products that, despite their low nominal value, contain components of interest. In this context, the present study examined the ability of the oleaginous yeast Cryptococcus curvatus ATCC 20509 to grow on whey permeate, known also as secondary cheese whey (SCW) and to produce bioproducts with immunomodulatory potential. The strain was cultivated in a fed-batch bioreactor under two feeding strategies: (i) pulses of concentrated lactose solution to induce lipid accumulation, and (ii) pulses of concentrated, microfiltered SCW. Under lactose feeding, the strain achieved the highest dry biomass (94.9 g/L), and lipid production (52.2 g/L) reported for this species on this kind of substrate. Microbial lipid production was one of the highest ever reported in the international literature. Under SCW feeding, biomass reached 39.1 g/L with a balanced lipid–polysaccharide composition (32.1% and 34.8% w/w, respectively). In both cases, lipids were rich in unsaturated and polyunsaturated fatty acids, especially oleic acid, while polysaccharides contained high β-glucan levels. Whole total dry cell biomass, lipid-free biomass, and extracted lipids from the second fed-batch case were then evaluated for immunomodulatory activity in PMA-differentiated, LPS-challenged THP-1 macrophages. This is the first study to assess C. curvatus bioproducts as modulators of inflammatory responses. The lipid fraction exhibited anti-inflammatory effects, whereas lipid-free biomass digestates exhibited mild pro-inflammatory activity.
No takes yet. Share an insight, caveat, or question.
Vasilakis et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: